-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session
-
-
-
-
-
-
-
Roth/MKM on Fortress Biotech (FBIO): 'Multiple Catalysts on Tap for 2024'
-
-
-
-
-
-
-
Moderna (MRNA) PT Raised to $125 at Jefferies ahead of RSV launch and CMV data
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Completes Acquisition of Karuna Therapeutics (KRTX)
-
-
-
-
-
-
-
Geron Corporation (GERN) PT Raised to $5 at Goldman Sachs
-
-
-
-
-
-
-
Laidlaw Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
UBS Says Moderna (MRNA) Management Sounds Confident Following Fireside Chat Ahead of Potential Ph3 CMV Data
-
12,341 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All